At the news
? NEUTRALIMPACT 2/10 144 filed Jun 18, 2026 at 15:26 ET
Former director Paul Sagan filed a Form 144 notice of intent to sell 25,770 shares of Moderna common stock, valued at approximately $1.66 million, acquired via stock option exercise. The proposed sale is small relative to Moderna's $24.5B market cap and represents a routine insider transaction with limited signaling value.
- Former director Paul Sagan filed Form 144 to sell 25,770 shares of MRNA common stock.
- Estimated market value of proposed sale: $1,663,874.56.
- Shares were acquired through a stock option exercise on the same date (06/18/2026).
- Sale represents ~0.007% of Moderna's $24.5B market cap.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access